Andrew Parker, Ph.D.CSO & SVP, Head of Research & External Innovation at Zealand Pharma A/S
Andrew Parker is CSO and SVP Head of Research with Zealand Pharma. Andrew has more than twenty years of experience from senior leadership and managerial positions in international pharmaceutical, biotech and start-up companies, including several years with Shire Pharmaceuticals, Opsona Therapeutics, and AstraZeneca to mention a few. More recently Andrew was General Partner with the Life Sciences Investment Fund Eclosion2 taking leadership roles in portfolio companies. He holds a Ph.D. from the National Institute for Medical Research at Mill Hill, London, conducted post-doctoral research at Johns Hopkins Medical School, Baltimore, USA, and also has an MBA from the University of Warwick Business School, UK.